4/A//SEC Filing
Valantine Hannah 4/A
Accession 0000950170-25-091756
CIK 0001743881other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 5:46 PM ET
Size
5.9 KB
Accession
0000950170-25-091756
Insider Transaction Report
Form 4/AAmended
Valantine Hannah
Director
Transactions
- Purchase
Common Stock
2021-12-28$13.16/sh+796$10,475→ 2,687 total(indirect: By Spouse) - Purchase
Common Stock
2021-12-28$12.68/sh+1,542$19,553→ 1,542 total
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001855608
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 5:46 PM ET
- Size
- 5.9 KB